melatonin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases pittsburgh Sleep Quality Index global score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“Mean PSQI score post treatment was lower in the melatonin group compared to placebo (P = 0.037).”
Quoted verbatim from Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- 0.5 mg fast-release melatonin orally 1 h before desired bedtime, at least 5 nights per week
- Population
- 116 randomised adults aged 16 to 65 with delayed sleep-wake phase disorder and delayed melatonin rhythm; behavioural sleep-wake scheduling in both arms; post-treatment at 4 weeks
Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.2018PMID:29912983An author is affiliated with a producerPermalink
Keep reading
- Everything the graph holds on melatonin
- Every compound studied against Pittsburgh Sleep Quality Index global score
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5KBPA2Q5DC4R30SXNANQM5B